These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9698934)

  • 1. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro.
    Alves AC; Pires AL; Lagente V; Cordeiro RS; Martins MA; e Silva PM
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():201-4. PubMed ID: 9698934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
    Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
    Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
    Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
    Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
    Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
    Dent G; Giembycz MA; Rabe KF; Barnes PJ
    Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
    Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
    Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils.
    Kaneko T; Alvarez R; Ueki IF; Nadel JA
    Cell Signal; 1995 Jul; 7(5):527-34. PubMed ID: 8562314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression.
    Momose T; Okubo Y; Horie S; Suzuki J; Isobe M; Sekiguchi M
    Int Arch Allergy Immunol; 1998 Oct; 117(2):138-45. PubMed ID: 9784658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.
    Ortiz JL; Vallés JM; Martí-Cabrera M; Cortijo J; Morcillo EJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):200-6. PubMed ID: 8717161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sephadex induces eosinophil migration to the rat and mouse peritoneal cavity: involvement of mast cells, LTB4, TNF-alpha, IL-8 and PAF.
    Oliveira SH; Costa CH; Ferreira SH; Cunha FQ
    Inflamm Res; 2002 Mar; 51(3):144-53. PubMed ID: 12005205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity.
    Barnette MS; Manning CD; Cieslinski LB; Burman M; Christensen SB; Torphy TJ
    J Pharmacol Exp Ther; 1995 May; 273(2):674-9. PubMed ID: 7752069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R; Coëffier E; Vargaftig BB
    J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.